FM-381 | m-entrepreneurship.com

Product Name :
FM-381

Search keywords :
FM-381

drugId :
null

Target Vo:
Tyrosine-protein kinase JAK3

Target Vo Short Name :
JAK3

Moa_Name:
Tyrosine-protein kinase JAK3 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Eberhard Karls University Tübingen

Active Company_Name :
Eberhard Karls University Tübingen

Active Indication_Name:
Inflammation

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RAGE Antibody
HDAC6 Antibody
VEGFA Antibody: VEGFA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to VEGFA. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts